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Abstract. This study compared the costs and effects of insecticide (permethrin)-treated bed net (ITN) use in children
less than five years of age in an area of intense, perennial malaria transmission in western Kenya. The data were derived
from a group-randomized controlled trial of ITNs conducted between 1996 and 1999. The annual net cost per life-year
gained was U.S. $34 and the net annual cost per all-cause sick child clinic visit averted was U.S. $49. After taking into
account a community effect (protection from malaria afforded to non-ITN users who lived within 300 meters from users)
these estimates decreased to U.S. $25 and U.S. $38, respectively. This study provides further evidence that ITNs are a
highly cost-effective use of scarce health care resources.
INTRODUCTION
Randomized controlled trials in various malaria transmis-
sion settings have shown insecticide (permethrin)-treated bed
nets (ITNs) to be effective in reducing child mortality.1–4
While there is a small but growing literature on the cost-effec-
tiveness of ITNs,3,5–7 no information on cost-effectiveness in
areas of intense, perennial malaria transmission is available.
In addition, we know little about the extent to which the
impact of ITNs on community members lacking ITNs (the
mass effect8 or community effect9) influences estimates of
cost-effectiveness. This economic evaluation is based upon
the results of a community-based, group-randomized, con-
trolled trial of ITNs in western Kenya conducted in an area of
intense, perennial malaria transmission. This paper has two
aims. The first is to evaluate the cost-effectiveness of ITNs in
children less than five years of age using mortality and num-
ber of sick child visits to local health facilities as the key
outcome variables. The second is to evaluate the impact on
cost-effectiveness of the protection afforded to those who do
not use ITNs who live in proximity (<300 meters) to house-
holds with ITNs. In economic terminology, this community
effect is a form of externality (Hanson K, Goodman C, Lines
J, Meek S, Bradley D, Mills A, 2002. The Economics of Ma-
laria Control. Malaria in Human Affairs: A collaboration be-
tween the Harvard University Center for International De-
velopment, the London School of Hygiene and Tropical
Medicine and the World Bank: Roll Back Malaria, World
Health Organization. http://mosquito.who.int/cmc_upload/0/
000/015/605/ea_ch2.pdf.), but for the purposes of this paper
and for consistency with other papers in this supplement, we
will use the term community effect.
MATERIALS AND METHODS
ITN study. The group-randomized ITN study was con-
ducted in a 500 km2 area of western Kenya in the contiguous
sites of Asembo and Gem. Details of the study are reported
elsewhere.10 The intervention was conducted from January
1997 to March 1999 in Asembo and from January 1998 to
December 1999 in Gem. The primary objective of the study
was to measure the effect of ITNs on all cause mortality of
children 1–59 months of age. The study also estimated the
effect of the intervention on all cause sick child visits (SCV)
to local clinics (in Asembo only). To estimate the community
effect of ITNs, epidemiologic data were linked to a base map
generated using the global positioning system.9 Costs for the
intervention were estimated from project expenditure
records. Information on community costs was gathered
through interviews with field staff and community members.
Resource use was categorized in accordance with three
phases of the project: start-up, distribution, and insecticide
treatment. In the start-up phase, meetings were held in each
village to inform community members about the study ratio-
nale and design, and to provide an opportunity to ask ques-
tions. In the distribution phase, program staff distributed
45,667 polyester, 100-denier, 156-mesh bed nets, pre-treated
with the target dose of 0.5 g of permethrin/m2 of netting. This
achieved an initial coverage ratio of 1.34 persons per ITN.
The ITNs were distributed by project staff at central points in
each village following a pre-arranged schedule. Each family
was responsible for sending one representative to collect the
nets and to receive training in how to hang them. Study staff
later visited all the houses to ensure that ITNs were properly
deployed. Re-treatment of nets with permethrin was sched-
uled every six months during the two-year intervention. Prior
to each re-treatment exercise, villages were notified in ad-
vance of the day the ITNs were to be re-treated. Program staff
visited each compound and re-treated the nets with the help
of community members, who provided water and labor.
Methods for the economic evaluation. The framework for
the economic evaluation (Table 1) was adapted from Drum-
mond and others.11 Costs and effects for all parties affected
by the intervention were included (i.e., users, community, and
program providers). Both financial and economic costs were
estimated. Research costs were not included. Financial costs
represent funds paid for the implementation of the interven-
tion by the project and are spread over a four-year period
(1996–1999). Cost-effectiveness ratios are based on net (av-
erage) annual economic costs. It is not uncommon in ITN
trials for the effectiveness data and cost estimates to be
spread over different time periods.6,12 In this study, costs cov-
ered a four-year period and effects were measured over a
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two-year period (two years in Asembo and two years in
Gem). The method used to measure and value capital costs
involved annuitizing the initial capital cost over the useful life
of each asset; that is, an equivalent annual cost has been
estimated that is then added to the annual recurrent esti-
mate.11 This process reflects the value-in-use of capital terms,
rather than reflecting when the item was purchased. Eco-
nomic costs differ from financial costs in two respects: an
equivalent annual capital cost has been calculated and the
value of community labor included.6 This was done to more
accurately reflect the opportunity cost of resource use. Finan-
cial costs and economic costs are converted to U.S. dollars at
the prevailing rate of exchange and deflated to 1996 values
using the U.S. gross domestic product deflator. The official
exchange rate at that time (1 U.S. $  78 Kenyan Shillings)
was assumed to reflect the scarcity of foreign exchange.
For each phase of the program, costs were separated into
capital and recurrent costs. The recurrent costs borne by the
providers were insecticides, detergent, personnel, office sup-
plies and services, and transport. The community recurrent
costs included water, transport, and the time spent washing,
drying, and re-deploying the ITNs. Capital costs, all incurred
by the provider, included bed nets, vehicles, buildings, office
equipment, furniture, and supplies for impregnation. The total
annual cost of the ITN program was obtained by summing the
provider and community costs (both recurrent and capital).
Costs for project personnel, consumables, and transport
were valued using current market rates. The insecticide was
valued at the duty-free purchase price; the effect of variation
in insecticide price was evaluated in the sensitivity analysis.
Project personnel were valued according to existing salary
scales. The difference in salaries of local and expatriate staff
was accepted on the basis that the opportunity cost of expa-
triates was higher because of easier access to international
labor markets.6 The community members who washed and
re-deployed the nets did not receive a formal wage. Their
time was valued using the estimated daily wage for a farm
worker (US $1.30 per day). The effect on net annual costs of
varying the value of unwaged time and the number of senior
staff salaries was also evaluated in the sensitivity analysis.
The costs of vehicles and equipment were annuitized over
an expected life of 10 years and at a discount rate of 3%. ITNs
were treated as a capital item and converted to an annual
equivalent cost assuming a 5-year life span and a 3% discount
rate. The effect on total costs of varying the discount rate was
also tested.
Effectiveness. Three measures of effectiveness were calcu-
lated. First, the number of all-cause child deaths prevented by
ITN use was estimated.13 Second, life-years gained (LYG)
were estimated by applying life expectancy at mean age of
death of trial participants to deaths averted. A 3% discount
rate was then applied to derive an estimate of discounted
life-years gained (DLYG).5 Third, morbidity was measured in
terms of the number of all-cause sick child clinic visits
averted.14 The effect of ITNs on all-cause mortality was ap-
parent only in infants 1–11 months of age, but all children less
than five years of age benefited from reduced morbidity.13,14
Since an impact on both child morbidity and mortality was
observed in compounds lacking ITNs located within 300
meters of intervention villages, estimates of effectiveness with
and without this community effect have been calculated. A
detailed description of efficacy measures including spatial
analyses and the effect of ITNs on nearby compounds lacking
ITNs are reported in detail elsewhere.9,13,14
Resource savings. Resource savings to the health sector
and households were also measured. Savings to the health
sector were based on the potential reduction in health service
use as measured by the difference in the absolute number of
all-cause sick child clinic visits to local health centers averted
by ITNs.14 The potential saving to the clinic was based on an
estimate of the cost of drugs prescribed by clinic staff to sick
children 59 months of age. These drugs, when available, are
normally provided free of charge by government clinics for
this age group, and non-dispensing thus provides a direct sav-
ing to the clinic. An estimate of the drug costs was obtained
from a previous study conducted in similar peripheral health
facilities in a neighboring province (U.S. $0.44 [1996 U.S. $]
per child per visit).15 We assumed that a reduction in sick
child visits would not result in a reduction in the infrastruc-
tural costs (e.g., maintenance and salary costs) of the clinic in
the short term.
At the household level, saved treatment costs and the eco-
nomic benefit of postponed funeral expenses were calculated.
Health care expenses were assessed during a series of cross-
sectional surveys16 and broken down into five categories paid
by the household for treating children less than five years of
age: medicines; doctor or clinic fees; laboratory (e.g., needles,
syringes, and tests); traditional healer (for fees, herbs, etc.);
and other items such as food and travel costs associated with
obtaining health care.17 It is important to note that funeral
costs can be a serious economic burden to poor families. It is
therefore relevant in such contexts to estimate the economic
benefit associated with delaying funeral payment. Based upon
an informal survey among local residents, funeral costs were
estimated to be approximately $100 per funeral. This con-
sisted primarily of the cost of the coffin and other costs of
arranging the funeral, which may include providing meals
for numerous guests over a period of several days. The effect
on net annual costs of lowering funeral costs by 50% and
of varying the discount rate was tested in the sensitivity analy-
sis.
Methods of analysis. Six cost-effectiveness ratios were cal-
culated: 1) cost per child death averted; 2) cost per LYG; 3)
cost per DLYG; 4) cost per SCV averted; 5) cost per person
protected; and 6) cost per ITN. In addition, net cost-
effectiveness ratios were calculated by subtracting resources
saved from the total economic cost divided by the relevant
outcome measure. Two sets of net cost-effectiveness ratios
were calculated: those that did not account for the community
effect, and those that did.
TABLE 1
Description of measures of costs and effects
Costs
Financial cost of the program (i.e., funds paid out for the program
by the project)
Economic cost of the program (i.e., costs borne by the project and
community)
Individual and community health effects
Number of all-cause sick child visits averted
Deaths averted
Resource savings
Resource savings to the health sector
Resource savings to households and the community
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The sensitivity of our results to variation in the discount
rate was examined by increasing the rate to 6% and to 10%.5,7
The effect on net annual costs of reducing the frequency of
re-treating ITNs from twice a year to once a year was also
determined.12 The cost of insecticide was reduced by 20% to
reflect the possibility of using cheaper insecticides in the fu-
ture5,18 The cost of insecticide was also increased by 20% to
explore the effect of using duty-free prices. Since it is likely
that fewer senior staff salaries would be required in a non-
research setting, the effect of a 50% reduction in staff salaries
has been calculated. Finally, the effect of varying the value of
the time of community members who washed and re-
deployed the ITNs as well as a reduction in funeral costs was
estimated.
RESULTS
Total financial costs. The capital and recurrent financial
costs of the intervention in local currency, excluding research
costs, are shown in Table 2. The total financial cost of the
program was U.S. $725,700. Recurrent costs were 57% of
total program costs. Staff salaries represented the largest re-
current cost item at 31%. Insecticide (permethrin) repre-
sented 8% of total recurrent costs. A total of 45,667 ITNs
were distributed. The annual capital cost of the program was
U.S. $320,000, with ITNs being the main capital item at U.S.
$230,000.
Total economic costs. The annual economic cost of the pro-
gram was U.S. $148,856 (Table 3). The key differences be-
tween Tables 2 and 3 is that for the latter, the imputed value
of user labor is included and capital costs have been annu-
itized to provide an equivalent annual cost. Approximately
25% of annual economic costs were attributed to program
start-up ($37,214), 40% to ITN distribution ($59,542), and
35% to retreatment ($52,100). The ITNs represented an av-
erage annual cost of U.S. $60,193 (40%) and insecticide rep-
resented a cost of U.S. $13,707 (9%).
Effectiveness and resource savings.We report elsewhere
that ITNs were associated with a 27% reduction in the num-
ber of sick child (less than five years old) visits to local health
facilities.14 This translates to an annual reduction of 2,025
visits per year in a population of 9,375 children less than five
years old, or 2,328 visits when the community effect is taken
into account. Based on a protective efficacy estimate of
23%,13 ITNs were also predicted to reduce all-cause post-
neonatal mortality by 61 deaths per year in the same popu-
lation (2,005 infants 1–11 months old), or 73 deaths when
additional benefits to the community are accounted for
(Table 4).
The reduced number of clinic visits results in an annual
saving to the health services of U.S. $891 (U.S. $ 0.44 per
visit), or U.S. $1,024 when adjusting for the community effect
(Table 4). Households in ITN villages spent approximately
U.S. $6.5 per year less on health care for sick children less
than five years old compared with those in the control vil-
lages.17 There were approximately 6,700 households with chil-
dren in this age range in the ITN villages in Asembo and
Gem, and 8,241 households if the communities located within
300 meters from ITN villages were also included. This repre-
sents an annual cost saving of U.S. $43,550, or $53,567 after
adjusting for the community effect. Savings also accrued to
households in the form of postponed funeral expenses with an
average discounted saving of $77 per year. When we adjusted
for the community effect, annual direct resource savings to
the community amounted to $5,621. These estimates are
based on 1) an average life expectancy at birth of 49 years;19
TABLE 2
Financial costs (US $ 1996) associated with the implementation of the intervention by the program*
Item 1996 1997 1998 1999 Total Cost profile (%)
Capital costs
Vehicles (4) 80,000 80,000 11
Furniture/equipment 10,000 10,000 1
ITNs 92,000 138,000 230,000 31
Subtotal 182,000 138,000 320,000 43
Recurrent (direct) costs
Permethrin 22,080 33,120 55,200 8
Staff 25,000 60,000 80,000 60,000 225,000 31
Fuel/maintenance 10,000 15,000 24,000 20,000 69,000 10
Office rental 1,000 1,000 1,500 1,000 4,500 1
Training 5,000 5,000 10,000 1
Supplies 10,000 10,000 12,000 10,000 42,000 6
Subtotal 51,000 113,080 150,620 91,000 405,700 57
Total 233,000 251,080 150,620 91,000 725,700 100
* ITNs  insecticide-treated bed nets.
TABLE 3
Annual economic cost*
Item
Average annual equivalent
cost (1996 $)
Cost
profile (%)
Program capital costs
ITNs 60,193 40.4
Vehicles 9,378 6.3
Equipment 1,172 0.8
Subtotal 70,743 47.5
Program recurrent costs
Insecticide 13,707 9.2
Staff 31,311 21.0
Fuel/maintenance 16,805 11.3
Office rental 1,100 0.7
Training 2,479 1.7
Supplies 10,266 6.9
Subtotal 75,668 50.8
User/community recurrent costs
Water 845 0.6
Transport 500 0.3
Time/Labor 1,100 0.7
Subtotal 2,445 1.6
Total 148,856 100
* ITNs  insecticide-treated bed nets.
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2) a discount rate of 3%; 3) an estimated reduction in total
number of post-neonatal deaths (age  1–11 months) by 73;
and 4) and an average cost per funeral of U.S. $100. This
figure was U.S. $4,697 if the community effect was not taken
into account (Table 4).
Cost-effectiveness. Table 4 also shows the cost-effec-
tiveness ratios both adjusted and unadjusted for the commu-
nity effect. Approximately 62,500 adults and children were
protected by the intervention at an estimated economic cost
of U.S. $1.4 per person protected per year (U.S. $1.6 unad-
justed). Among the children 1–11 months of age, 3,540 life-
years of protection were achieved at the end of the first year
at a cost of U.S. $25 per infant (U.S. $34 unadjusted). This is
based on an estimate of 48.5 life-years gained at the median
age of death (six months) of trial infants (48.5 life-years
gained × 73 deaths averted  3,540 life-years of protection).
A total of 73 child deaths were prevented by the use of ITNs
at an annual cost of U.S. $1,214 per death averted (U.S.
$1,635 unadjusted). Applying a discount rate of 3%,3 each
death prevented was equivalent to approximately 25 DLYG
or a total of 1,825 life-years of protection. This represented an
estimated cost of U.S. $49 per DLYG (U.S. $65 unadjusted).
The annual net cost per SCV averted is U.S. $38 (U.S. $49
unadjusted) or U.S. $1.9 per ITN (U.S. $2.2 unadjusted).
Sensitivity analysis. The sensitivity of net annual costs to
changes in the discount rate, frequency of net impregnation,
cost of insecticide and salary, or wage levels is shown in Table
5. While this analysis includes the community effect, the es-
timated changes in total cost are the same or within 1–3 per-
centage points of the estimates generated using the unad-
justed figures. Increasing the discount rate applied to both
capital and funeral costs from 3% to 6% or from 3% to 10%
would increase the cost of the intervention by approximately
4% and 11%, respectively. The cost per child death averted
would then increase from U.S. $1,214 to U.S. $1,265 or U.S.
$1,354.
Reducing the frequency of bed net re-treatment to once a
year also reduced the cost of the intervention by an estimated
29% with a concomitant reduction in the cost per child death
averted from U.S. $1,214 to U.S. $857. A decrease in the cost
of insecticide of 20% led to a reduction in the cost per child
death averted from U.S. $1,214 to U.S. $1,176 (or in the case
of a 20% increase in insecticide, U.S. $1,252), representing a
mere 3% change in cost. If a 20% lower cost of insecticide is
combined with yearly re-treatment, costs are reduced by 30%
and the cost per child death averted decreases from U.S.
$1,214 to U.S. $839.
The effect of valuing unwaged time at 25% above or 25%
below $1.30 per day changed costs by only 0.3%. However,
costs were reduced by 17% to $72,988 per annum by a 50%
reduction in senior staff salaries. A 50% decrease in funeral
costs was associated with a 3% reduction in costs.
In a separate analysis of effects, the discount rate applied to
life-years gained varied from 3% to 6% and from 3% to 10%.
This led to an increase in the net cost per discounted life-year
gained from $49 to $76 and $121, respectively.
DISCUSSION
Several studies have shown that ITNs are a cost-effective
malaria control intervention in African communities.20–22
This study provides the first evidence that the cost-
effectiveness of the intervention in areas with intense, peren-
nial malaria transmission is comparable to that found in other
TABLE 4
Summary of costs, effects, and cost-effectiveness*
Community
effect not
included
Community
effect
included
Costs
Annual economic cost of ITN program 148,856 148,856
Annual cost savings (see Results) −49,138 −60,212
Net annual cost 99,718 88,644
Effects (per year)
Number of persons protected 62,500 62,500
Number of all-cause child deaths (1–11
months old) averted
61 73
Life-years gained (LYG) 2,959 3,540
Discounted life-years gained (DLYG)
at 3%
1,525 1,825
Number of all-cause sick child visits
(<5 years) averted
2,025 2,328
Number of ITNs 45,667 45,667
Resource savings
Community: discounted funeral
expenses
4,697 5,621
Community: reduced expenditure on
treating ill children
43,550 53,567
Health service: reduced expenditure on
health center visits
891 1,024
Cost-effectiveness
Net cost per person protected 1.6 1.4
Net cost per all-cause child death
averted
1,635 1,214
Net cost per LYG 34 25
Net cost per DLYG at 3% 65 49
Net cost per all-cause sick child visit
averted
49 38
Net cost per ITN 2.2 1.9
* ITNs  insecticide-treated bed nets.
TABLE 5
Effect of sensitivity analysis on net annual economic costs*
Variable Effect on total economic cost
Discount rate (applied
to capital and
funeral costs)
Increasing the discount rate of 3%
to 6% and from 3% to 10% would
increase the cost of the interven-
tion by 4% and 11%, respectively
Frequency of net
impregnation
Reducing the frequency of net im-
pregnation to once a year reduces
total costs by 29%
Cost of insecticide A 20% reduction (or increase) in
the cost of insecticide reduces (or
increases) total costs by 3%
Frequency of net
impregnation and
cost of insecticide
Reducing net impregnation to once a
year and reducing the cost of in-
secticide by 20% reduces total
costs by 30%
Unwaged labor Valuing unwaged time at 25% above
and 25% below $1.30 per day
leads to a 0.3% change in total
costs
Wages of program staff A 50% reduction (or increase) in
salaries would decrease (or in-
crease) total costs by 17%
Funeral costs A 50% reduction in funeral costs
results in a 3% reduction in total
costs
* Estimates include any resource savings from the community effect.
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epidemiologic settings. The net cost-effectiveness estimates
reported in this study, U.S. $25 per LYG and $1,214 per death
averted, fall well within the range of previously reported es-
timates.20 For example, estimates from The Gambia, where
bed net use was high and only insecticides had to be provided,
indicate a gross cost per death averted of U.S. $2196 and U.S.
$665. At the other end of the range are estimates of $2,003
and $2,958 for Ghana5 and coastal Kenya,23 respectively. In
these latter two areas, as is the case in western Kenya, initial
bednet coverage was low so both bed nets and insecticide had
to be provided. A number of factors make it difficult to com-
pare the cost-effectiveness of ITNs with other malaria control
interventions, most notably, the small evidence base and the
variety of assumptions underlying the different analyses.
Nonetheless, analyses such as this one would indicate that
ITNs are cost-effective according to the guideline that any
intervention with a cost per DLYG less than $150 may be
considered an attractive use of scarce health care resources in
low-income countries.24
This study also demonstrates that estimates of cost-
effectiveness are markedly affected when effects of ITNs on
those lacking ITNs are taken into account. Taking beneficial
effects in this larger population into account resulted in a
decrease in cost-effectiveness ratios by about one-fourth. The
annual net cost per LYG decreased from U.S. $34 to U.S. $25
after adjusting for the community effects of ITNs. Similarly,
the net annual cost per SCV averted decreased from U.S. $49
to U.S. $38 after adjusting for this effect. It is important to
note that the magnitude of the community health effects will
be influenced by population density in areas neighboring in-
tervention zones. Such effects may be less relevant to islands
or isolated refugee camps where proximate fringe populations
may not exist. In contrast, it is possible that the community
effect might be stronger in areas where the absolute popula-
tion density is higher than that of the relatively dispersed
western Kenya population.
The estimate of community effects and their inclusion in
economic analyses raises a number of important issues for
debate. In economic terms, this community effect is a positive
externality. In making their choices, individuals will not nec-
essarily take into account these additional positive effects and
may consume less than the socially optimal amount, which is
the amount that would be consumed if markets prices existed
for these effects. Focusing government intervention on the
alleviation of this form of market failure overlooks factors
that influence the willingness and ability of health care pro-
viders to distribute nets solely on the basis of maximizing
efficiency. There may be compelling ethical and social rea-
sons why those responsible for the delivery of ITNs choose to
target certain groups of individuals or to consider a policy of
complete coverage. Much will depend on the resources avail-
able and on the equity and efficiency goals of local and inter-
national decision-makers.
In addition, cost-effectiveness depends upon several inter-
acting factors including the definition and measurement of
resource savings. In this study, we estimated resource savings
in three different ways (i.e., direct savings to the health sec-
tor and both direct and indirect savings to the community),
allowing us to calculate net, rather than gross cost-
effectiveness ratios. Resource savings (without adjustment
for the community effect) were 33% of total costs. Most of
these savings resulted from accumulated small reductions
in community-borne costs for treating sick children. At the
community level this form of saving might be viewed as neg-
ligible ($6.50 per household per year),17 but the overall effect
on the adjustment of gross cost-effectiveness ratios was sub-
stantial.
As for most economic evaluations of ITN programs, our
analysis used permethrin as the insecticide. In recent years,
other synthetic pyrethroids have entered the market, which
are both cheaper and longer lasting. Our sensitivity analysis
indicated that replacement of permethrin with an insecticide
20% lower in cost requiring only yearly application would
result in a 30% lower cost-effectiveness ratio. The results of
similar sensitivity analyses conducted in other studies are con-
sistent with this finding.6,7 However, it should be noted that
re-treatment annually, as opposed to every six months, might
result in lower levels of effectiveness. If this is the case, then
any reduction in cost may be counter balanced by a reduction
in effectiveness.
Details of delivery mechanisms will also impact upon cost-
effectiveness.25,26 In a recent study in Kenya, re-treatment
levels of a bi-annual house-to-house re-treatment schedule
provided free of charge were compared with a social market-
ing approach that introduced cost-retrieval. The free re-
treatment service achieved re-treatment levels between
61% and 67%, while the social marketing approach yielded
a very low re-treatment rate of 7%.26 In our study, project
staff were mainly responsible for bed net re-treatment. While
no fee was charged for this service, it is important to recog-
nize that financial constraints may lead to cost recovery mea-
sures which in turn impact on levels of coverage and adher-
ence.
Finally, the cost-effectiveness analyses of efficacy trials may
not reflect operational settings. Trial participants may be
more likely to exhibit higher levels of adherence than those in
programmatic settings. Evans and others26 illustrated the sig-
nificant effect the level of adherence has on cost-effectiveness
estimates. However, relative effects of coverage and adher-
ence are difficult to judge because infants not sleeping under
ITNs may still benefit from having an ITN in the house, or as
was demonstrated in this trial, having ITNs in many proxi-
mate houses. Moreover, this study focused on two groups,
those with nets and those without. In practice, however, some
families may already own a net and comparisons of cost and
effect would ideally be made across each of these groups.
Also the levels of cost-effectiveness described in this study
and, in particular, the positive benefits to non-users, rely on
the distribution of nets by randomized lottery. In practice,
different methods of distribution are likely to be used. These
variations in distribution are also expected to impact upon
estimates of both cost and effect.
In agreement with the findings of previous efficacy trial-
based modeling studies, our results show that ITNs are a
highly cost-effective use of scarce health care resources. How-
ever, there are a number of important ways in which our
results contribute to the existing knowledge base and stimu-
late debate. This study provides much needed information on
the cost-effectiveness of ITNs in areas of intense, perennial
malaria transmission. Cost savings to both the community and
to the health sector were also measured to allow for the es-
timation of net cost-effectiveness ratios. Few studies have
taken these potential savings from ITN use into account.5
Comparisons were also made across cost-effectiveness ratios
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that include a community effect and those that do not. While
some of the policy implications of using these different sets of
estimates to inform resource allocation have been raised, this
complex issue deserves greater attention by researchers.
These findings must also ultimately be balanced against mea-
sures of affordability and the operational challenges of maxi-
mizing levels of coverage, insecticide treatment, and adher-
ence.
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